Biggest News Aggregation in the World
📰 Accelerate Commercialization News

Page 3 - Accelerate Commercialization News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Accelerate Commercialization. Real-time updates on events, politics, business and more.

Perrigo's generics split is back on the docket, thanks to $1.55B Altaris offer

Perrigo is selling its prescription generics business to Altaris Capital Partners for $1.55 billion. The generics unit, which recently nabbed approval for a copycat version of Teva's ProAir HFA inhaler, will establish itself as a standalone company, investment firm Altaris said. The deal is expected to close by the end of the third quarter.
Murray Kessler Rosen Katz Garikai Nyaruwata Goldman Sachs Altaris Capital Partners Uncover Rare Disease Insights

Fierce Pharma Asia—Daiichi Sankyo's new R&D head; Clover's $230M raise; Insilico's AI breakthrough

Daiichi Sankyo, Clover Biopharmaceuticals and Insilico Medicine made our news this week. (Google) Amid a big cancer push, Daiichi Sankyo lured Kite Pharma exec Ken Takeshita to lead its R&D work. Chinas Clover Biopharmaceuticals secured $230 million in an oversubscribed series C to help advance its COVID-19 vaccine program and expand manufacturing capabilities. In several firsts for artificial-intelligence-based drug discovery, Insilico Medicine discovered a novel target for idiopathic pulmon...
South Korea United Kingdom Andhra Pradesh Ken Takeshita Ahn Jae Yong Daiichi Sankyo

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science